Bio-Regen Med
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bio-Regen Med - overview
Established
2011
Location
Xi'an, Shaanxi, China
Primary Industry
Medical Devices & Equipment
About
Based in Shaanxi, China, and founded in 2011, Bio-Regen Med is a medicine company engaged in developing and producing biomedical materials. The director and CEO, Yuxi Jin graduated from Michigan State University, U. S. A.
The company has set up industrial bases in Xi'an, Changshu, and Dongguan. It has acquired more than 260 technology patents and has been recognized as Xi'an Regenerative Medicine Engineering Technology Center. In 2021, the 3D tissue engineering technologized system was built. In January 2024, Bio-Regen Med closed a strategic investment led by Changan Huitong Capital.
The company's business involves medical devices, cosmetics, and innovative raw materials. It has launched products for the treatment of tissue and organ defects in bone and joint, eye, and oral plastic surgery. Bio-Regen also provides stem cell storage, stem cells for the treatment of disease, and basic research on stem cells. The main products are 3D skin modeling and corneal graft repair products.
The company operates brands including UFTexo, Bioyufen, Hiyus, etc. Bio-Regen Med plans to use the strategic investment funding for product development and marketing.
Current Investors
Kunlun Fund, CD Capital, Yushan Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Biotechnology, Aesthetic Medicine, Dermatology, Medical Devices & Equipment
Website
www.bio-reg.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.